NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease

The tremendous cost, pain and disability associated with degenerative disc disease (DDD) makes the development of a biological agent that can mitigate the course of DDD, a critical unmet need. We have identified and reported that a single injection of a combination of recombinant human (rh) Transfor...

Descripción completa

Detalles Bibliográficos
Autores principales: Matta, Ajay, Karim, Muhammad Zia, Gerami, Hoda, Jun, Peter, Funabashi, Martha, Kawchuk, Greg, Goldstein, Alyssa, Foltz, Warren, Sussman, Marshall, Eek, Bjorn C., Erwin, W. Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235869/
https://www.ncbi.nlm.nih.gov/pubmed/30429487
http://dx.doi.org/10.1038/s41598-018-35011-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6235869/
https://www.ncbi.nlm.nih.gov/pubmed/30429487
http://dx.doi.org/10.1038/s41598-018-35011-4

Ejemplares similares